| [1] |
Sung H, Ferlay J, Siegel RL, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J]. CA Cancer Clin，2021，71(3)：209-249.
|
| [2] |
Lyndin M，Hyriavenko N，Sikora V，et al. Invasive breast carcinoma of no special type with medullary pattern: morphological and immunohistochemical features[J]. Turk Patoloji Derg，2022，38(3)：205-212.
|
| [3] |
Lakhani SR，Ellis IO，Schnitt SJ，et al. World Health Organization classification of tumours of the breast[M]. 4th ed. Lyon: IARC Press，2012：45.
|
| [4] |
Aihara T，Kumamaru H，Ishitobi M，et al. Prognosis and effectiveness of chemotherapy for medullary breast carcinoma[J]. Breast Cancer Res Treat，2022，196(3)：635-645.
|
| [5] |
阚秀，沈丹华，陈定宝．关于乳腺"具有髓样特征的癌"的讨论[J/CD]．中华乳腺病杂志(电子版)，2013，7(5)：314-316.
|
| [6] |
Scarff RW，Torloni H. Histological typing of breast tumors[M]．Geneva: World Health Organization，1968：47.
|
| [7] |
Azzopardi JG.Histological typing of breast tumours[M]．Geneva: World Health Organization，1981：48.
|
| [8] |
刘彤华，廖松林，阚秀，等. 乳腺增生症及乳腺癌的组织学分类(推荐方案) [J]．中华病理学杂志，1997，26(6): 325-326.
|
| [9] |
Tavassoli FA，Devilee P. World Health Organization Pathologyand genetics of tumours of the breast and female genital organs[M]. Lyon: IARC press，2003: 24.
|
| [10] |
Lakhani SR，Ellis IO，Schnitt SJ.WHO classification of tumours of the breast[M]. Lyon: IARC Press，2012: 46.
|
| [11] |
Yang WT，Bu H. Updates in the 5(th) edition of WHO classification of tumours of the breast[J]. Zhonghua Bing Li Xue Za Zhi，2020，49(5)：400-405.
|
| [12] |
Abdul Rashid S，Rahmat K，Jayaprasagam K，et al. Medullary carcinoma of the breast: role of contrast-enhanced MRI in the diagnosis of multiple breast lesions[J]. Biomed Imaging Interv J，2009, 5 (4)：e27.
|
| [13] |
Aksoy A，Odabas H，Kaya S，et al.Hormone receptor status and survival of medullary breast cancer patients. A Turkish cohort[J]. Saudi Med J，2017，38(2)：156-162.
|
| [14] |
Perkins GH，Green MC，Middleton LP，et al. Hortobagyi, medullary breast carcinoma：outcomes and prognosis with the utilization of chemotherapy[J]. Clin Oncol，2004，22：671.
|
| [15] |
Wang XX，Jiang YZ，Liu XY，et al. Difference in characteristics and outcomes between medullary breast carcinoma and invasive ductal carcinoma: a population based study from SEER 18 database[J]. Oncotarget，2016，7(16)：22 665-22 673.
|
| [16] |
Romaniuk A，Lyndin M，Sikora V，et al. Histological and immunohistochemical features of medullary breast cancer[J]. Fol Med Cracov，2015，52：41-48.
|
| [17] |
Kim J，Kim JY，Lee HB，et al. Characteristics and prognosis of 17 special histologic subtypes of invasive breast cancers according to World Health Organization classification: comparative analysis to invasive carcinoma of no special type[J]. Breast Cancer Res Treat，2020，184(2)：527-542.
|
| [18] |
胡伊君，王文婉，郁领娣，等. 乳腺典型髓样癌临床分析[J]. 外科理论与实践，2004，9(3)：230-231.
|
| [19] |
孙阳阳，周晓莉，顾文贤，等. 23例乳腺具有髓样特征的癌临床病理分析[J/CD]. 中华乳腺病杂志(电子版)，2019，13(1)：44-49.
|
| [20] |
Pintican R，Duma M，Chiorean A，et al. Mucinous versus medullary breast carcinoma: mammography, ultrasound, and MRI findings[J]. Clin Radiol，2020，75(7)：483-496.
|
| [21] |
张玉静，成品秀，姜月，等. 多模态超声在乳腺髓样癌诊断中的应用价值[J]. 海南医学，2022，33(13)：1717-1720.
|
| [22] |
李素玲，鲁江斌. 超声自动乳腺全容积成像鉴别诊断乳腺髓样癌、乳腺纤维的价值[J]．贵州医药，2023，47(2)：285-286.
|
| [23] |
涂建国．磁共振成像在纤维腺瘤与乳腺髓样癌鉴别诊断中的应用[J]. 实用医技杂志，2020，27(11)：1454-1456.
|
| [24] |
Malyuchik SS, Kiyamova RG. Medullary breast carcinoma[J]. Exp Oncol，2008，30：96-101.
|
| [25] |
Park I，Kim J，Kim M，et al. Comparison of the characteristics of medullary breast carcinoma and invasive ductal carcinoma[J]. Breast Cancer，2013，16(4)：417-425.
|
| [26] |
Aksoy A，Odabas H，Kaya S，et al. Hormone receptor status and survival of medullary breast cancer patients. A turkish cohort [J]. Saudi Med，2017，38：156-162.
|
| [27] |
Zhao Y，Huang T，Jin X，et al. Clinicopathologic features and immune cell subtypes analysis of tumor-infiltrating lymphocytes richinvasive breast carcinoma of no special type[J]. Appl Immunohistochem Mol Morphol，2023，31(6)：354-362.
|
| [28] |
Zangouri V MD，Akrami M MD，Tahmasebi S MD，et al. Medullary breast carcinoma and invasive ductal carcinoma: a review study[J]. Iran J Med Sci，2018，43(4)：365-371.
|
| [29] |
Jiang YZ，Ma D，Suo C，et al. Genomic and transcriptomic landscape of triple-negative breast cancers: subtypes and treatment strategies [J]. Cancer Cell，2019，35(3)：428-440.
|
| [30] |
BudzikMP, SobierajMT，Sobol M，et al. Medullary breast cancer is a predominantly triple-negative breast cancer - histopathological analysis and comparison with invasive ductal breast cancer[J]. Arch Med Sci，2019，18(2)：432-439.
|
| [31] |
Lim KH，Telisinghe PU，Abdullah MS, et al. Possible significance of differences in proportions of cytotoxic T cells and B-lineage cells in the tumour-infiltrating lymphocytes of typical and atypical medullary carcinomas of the breast[J]. Cancer Immun，2010，10：3.
|
| [32] |
Tan PH，Ellis I，Allison K，et al. The 2019 World Health Organization classification of tumours of the breast[J]. Histopathology，2020，77(2)：181-185.
|
| [33] |
Mremi A，Gnanamuttupulle M，Ntundu SH，et al. Invasive breast carcinoma of no special type with medullary pattern: a case report at a tertiary facility in Tanzania[J]. Clin Case Rep，2023，11(8)：e7844.
|
| [34] |
Ridolfi RL，Rosen PP，Port A，et al. Medullary carcinoma of the breast: a clinicopathologic study with 10 year follow-up[J]. Cancer，1977，40(4)：1365-1385.
|
| [35] |
Romaniuk A，Lyndin M，Sikora V，et al. Histological and immunohistochemical features of medullary breast cancer[J]. Folia Med Cracov，2015，55：41-48.
|
| [36] |
Lyndin M，Hyriavenko N，Sikora V，et al. Invasive breast carcinoma of no special type with medullary pattern: morphological and immunohistochemical features[J]. Turk-Patoloji-Derg，2022，38(3)：205-212.
|
| [37] |
Lee M，Jara-Lazaro AR, Cheok PY, et al. Medullary breast carcinoma: a pathogenic review and immunohistochemical study using tissue microarray[J]. Singapore Med J, 2022，63(7)：394-401.
|